About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials | 4,038 Studies Recruiting

Clinical TrialsOvarian Cancer

Ovarian Cancer Clinical Trials

Browse 4,038 clinical trials for ovarian cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 681-700 of 4,038 trials

CompletedNanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR MutationsThis pilot trial studies how well nanoparticle albumin-bound rapamycin works in treating patients with cancer that as has spread to other places in the body and usually cannot be…NCT02646319·Scottsdale, Arizona and 1 other CompletedAncillary Study GOG 158: Survival Analysis Based on Reclassification to a Two-Tier Grading SystemPrimary Objective: * To reclassify the histologic grade of the serous ovarian cancer specimens of patients enrolled on Gynecologic Oncology Group (GOG) protocol 158 using a…NCT00837993·Houston, Texas

Related Searches

ovary cancertrials

Data from ClinicalTrials.govTerms

UnknownScreening and Identification of Ovarian CancersOvarian cancer is the first mortality rate of gynecologic malignancies.NCT00854399·Taipei

Active not recruitingVaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity CancerThis phase I/II trial tests the safety, side effects, best dose, and effectiveness of multi-epitope folate receptor alpha-loaded dendritic cell vaccine (FRalphaDC) with…NCT05920798·Scottsdale, Arizona and 2 others

UnknownEfficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC)This is a phase II/III randomized controlled trial to evaluate efficacy of platinum-based chemotherapy vs conventionally prescribed non-platinum monochemotherapy in patients with…NCT04055038·Moscow

CompletedCarboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerThis phase I trial studies the side effects and best dose of gemcitabine hydrochloride and mifepristone when given together with carboplatin in treating patients with breast…NCT02046421·Chicago, Illinois and 1 other

Completed'OLAP' (OLAparib Regulatory Post-marketing Surveillance)The objectives of this study are to assess safety and effectiveness of Lynparza tablet (olaparib, hereinafter "the study drug") in a real world setting in patients who are…NCT04553926·Ansan and 17 others

RecruitingTiming of Surgery After Neoadjuvant Chemotherapy for Advanced Ovarian CancerOvarian cancer is among the top five primary causes of cancer-related mortality in women.NCT06404671·Alexandria

CompletedPositron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility StudySometimes, cancer comes back after it has been successfully treated-a situation called recurrent cancer.NCT00686465·Hamilton, Ontario and 3 others

TerminatedA Safety Study of SEA-TGT (SGN-TGT) in Advanced CancerThis trial will look at a drug called SEA-TGT (also known as SGN-TGT) to find out whether it is safe for patients with solid tumors and lymphomas.NCT04254107·Birmingham, Alabama and 35 others

RecruitingInfluences of Propofol and Sevoflurane Anesthesia in Ovarian Cancer (Anesthetics)Ⅶ. Study procedures (summary) 1.NCT05606692·Kaohsiung City

RecruitingA Beta-only IL-2 ImmunoTherapY StudyThis is a Phase 1/2, multi-center, open-label, dose-escalation and expansion study to evaluate safety and tolerability, PK, pharmacodynamic, and early signal of anti-tumor…NCT05086692·San Diego, California and 26 others

CompletedAuranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CancerThis pilot clinical trial studies auranofin in treating patients with epithelial ovarian, primary peritoneal, or fallopian tube cancer.NCT01747798·Rochester, Minnesota

Not yet recruitingBenmelstobart in Combination With Anlotinib and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial OvariaN, Fallopian Tube, or Primary Peritoneal CancerEfficacy and safety of Benmelstobart combined with Anlotinib and oral metronomic Cyclophosphamide in the treatment of recurrent epithelial ovarian cancer, fallopian tube cancer or…NCT07489300

CompletedSafety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid TumoursThis is an open-label, multi-centre, Phase Ib study of AZD1775 designed to assess the safety, tolerability, pharmacokinetics, and anti-tumour activity of AZD1775 monotherapy in…NCT02482311·Fayetteville, Arkansas and 15 others

RecruitingA Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian CancerThe goal of this clinical trial is to learn if the experimental antibody COM701 delays the progression of ovarian cancer in participants with Relapsed Platinum Sensitive Ovarian…NCT06888921·Augusta, Georgia and 27 others

CompletedNeo-adjuvant Pembrolizumab in Primary Stage IV Ovarian CancerThis is a single arm feasibility study in patients with primary FIGO stage IV serous ovarian, peritoneal, or fallopian tube cancer to evaluate neo-adjuvant + adjuvant…NCT03126812·Amsterdam

RecruitingPhase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.This is a Phase 1 study to assess safety, tolerability, pharmacokinetics, immunogenicity, and antitumor activity of ARR-002 in advanced or metastatic ovarian or endometrial cancer.NCT07755436·Orlando, Florida and 5 others

CompletedIP ALT-803 Followed by SQ ALT-803 for Ovarian CancerThis is a single center, randomized phase II study of an IL-15Rα-Fc super-agonist complex (ALT-803) given as maintenance therapy after the completion of 1st line IV/IP…NCT03054909·Minneapolis, Minnesota

CompletedAlisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast CancerThis is an open-label, multicenter study with a nonrandomized Phase 1 portion and an open-label, randomized, Phase 2 portion evaluating MLN8237 in combination with weekly…NCT01091428·The Bronx, New York and 3 others

PreviousPage 35 of 202Next